Celero Systems

Lincoln, United States Founded: 2017 • Age: 9 yrs
An ingestible device for detecting opioid overdoses is developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 3 Services tracked
Competitors 8 Brand Intelligence

About Celero Systems

Celero Systems is a company based in Lincoln (United States) founded in 2017 by Giovanni Traverso. Celero Systems offers products and services including Digital Health Platform, Sleep Apnea Diagnostics, and Opioid Risk Management. Celero Systems operates in a competitive market with competitors including Pocket Naloxone, NIRLAB, Synens, Labb and ION-GAS, among others.

  • Headquarter Lincoln, United States
  • Founders Giovanni Traverso
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Celero Systems

Celero Systems offers a comprehensive portfolio of products and services, including Digital Health Platform, Sleep Apnea Diagnostics, and Opioid Risk Management.

Product name locked
Category locked
Primary

Platform for monitoring and diagnosing sleep apnea remotely.

Product name locked
Category locked
Locked

Tool for detecting sleep apnea through vital sign tracking.

Product name locked
Category locked
Locked

System for managing opioid risks via data analysis.

People of Celero Systems

Headcount 1-10
Employee Profiles 4
Board Members and Advisors 4
Employee Profiles
People
Dan Bacher
VP, R&D
People
Craig Patterson
CFO & VP, Business Development
People
Ben Pless
CEO & Founder
People
Shannon Schuetz
Senior Director, Operations

Unlock access to complete

Board Members and Advisors
people
Giovanni Traverso
Advisor
people
Robert Langer
Advisor
people
Jeremy Ruskin
Advisor
people
Ali Rezai
Advisor

Unlock access to complete

Funding Insights of Celero Systems

Premium access

Detailed funding history for Celero Systems

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Celero Systems

Investments
Premium access

Investment portfolio details for Celero Systems

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Celero Systems

Premium access

Detailed financials for Celero Systems

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Celero Systems Comparisons

Celero Systems Primary company
Description
An ingestible device for detecting opioid overdoses is devel...
Location
Lincoln, United States
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Celero Systems

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Celero Systems

Celero Systems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pocket Naloxone, NIRLAB, Synens, Labb and ION-GAS, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
FDA-approved devices for opioid overdose management are developed.
Locked Locked Locked
Offers handheld devices for instant material composition analysis using spectroscopy.
Locked Locked Locked
Provider of drug abuse detection devices
Locked Locked Locked
Mobile app for efficient drug testing and rapid results via various specimen types.
Locked Locked Locked
Develops customized analytical devices for medical, forensic, and quality assurance applications.
Premium access

Detailed competitors of Celero Systems

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Celero Systems

Premium access

Complete news archive for Celero Systems

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Celero Systems

Celero Systems was founded in 2017.

Celero Systems is headquartered in Lincoln, United States. It is registered at Lincoln, Nebraska, United States.

Benjamin Pless is the current CEO of Celero Systems.

Founded in 2017 and based in Lincoln, United States, Celero Systems operates in the medical device sector. An ingestible system is developed using proprietary technologies to detect opioid overdoses and deliver autonomous interventions. Mortality and injury from overdoses are addressed through timely responses provided by the device. Operations focus on integrating therapies for life-saving outcomes in the health technology field.

Celero Systems's top competitors include Pocket Naloxone, Synens and NIRLAB.

Celero Systems offers Digital Health Platform, Sleep Apnea Diagnostics, and Opioid Risk Management.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available